NCT05979675

Acute Myeloid Leukemia Registry

Acute Myeloid Leukemia Registry - Prospective National Multicentric Observational Study

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 250 (estimated)
• Sponsor: Turkish Hematology Association · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

All acute myeloid leukemia (AML) patients diagnosed after 1 Jan 2020 will be included to this study.

Detailed description

This is a non interventional prospective disease registry, 250 prospective patients diagnosed with AML across 20 centers in Turkey. Participating sites will consist of hematology clinics and routine follow-up procedures will be followed-up. All patients diagnosed after 1 Jan 2020 as AML will be included and patients will be enrolled during 24 months of period and will be followed-up 36 months. Study will be completed in 60 months.

Conditions

• Acute Myeloid Leukemia

Timeline

• Start date: 2021-12-21
• Primary completion: 2026-12-21
• Completion: 2026-12-21
• First posted: 2023-08-07
• Last updated: 2023-08-07

Locations

1 site across 1 country: Turkey (Türkiye)